FGHQF
Price
$0.10
Change
-$0.02 (-16.67%)
Updated
Jun 21 closing price
Capitalization
280.99M
ZVRA
Price
$12.01
Change
+$0.45 (+3.89%)
Updated
Jul 10, 04:59 PM (EDT)
Capitalization
632.1M
39 days until earnings call
Interact to see
Advertisement

FGHQF vs ZVRA

Header iconFGHQF vs ZVRA Comparison
Open Charts FGHQF vs ZVRABanner chart's image
Frontage
Price$0.10
Change-$0.02 (-16.67%)
Volume$100K
Capitalization280.99M
Zevra Therapeutics
Price$12.01
Change+$0.45 (+3.89%)
Volume$28.51K
Capitalization632.1M
FGHQF vs ZVRA Comparison Chart in %
Loading...
ZVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FGHQF vs. ZVRA commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FGHQF is a Buy and ZVRA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (FGHQF: $0.10 vs. ZVRA: $12.02)
Brand notoriety: FGHQF and ZVRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FGHQF: 100% vs. ZVRA: 218%
Market capitalization -- FGHQF: $280.99M vs. ZVRA: $632.1M
FGHQF [@Biotechnology] is valued at $280.99M. ZVRA’s [@Biotechnology] market capitalization is $632.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FGHQF’s FA Score shows that 0 FA rating(s) are green whileZVRA’s FA Score has 1 green FA rating(s).

  • FGHQF’s FA Score: 0 green, 5 red.
  • ZVRA’s FA Score: 1 green, 4 red.
According to our system of comparison, ZVRA is a better buy in the long-term than FGHQF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ZVRA’s TA Score shows that 5 TA indicator(s) are bullish.

  • ZVRA’s TA Score: 5 bullish, 4 bearish.

Price Growth

FGHQF (@Biotechnology) experienced а 0.00% price change this week, while ZVRA (@Biotechnology) price change was +23.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.89%. For the same industry, the average monthly price growth was +16.25%, and the average quarterly price growth was +20.89%.

Reported Earning Dates

ZVRA is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+9.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZVRA($632M) has a higher market cap than FGHQF($281M). ZVRA YTD gains are higher at: 44.125 vs. FGHQF (0.000).
FGHQFZVRAFGHQF / ZVRA
Capitalization281M632M44%
EBITDAN/A-60.3M-
Gain YTD0.00044.125-
P/E Ratio34.83N/A-
RevenueN/A40.6M-
Total CashN/A62.6M-
Total DebtN/A61.8M-
FUNDAMENTALS RATINGS
ZVRA: Fundamental Ratings
ZVRA
OUTLOOK RATING
1..100
29
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
57
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
25
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FGHQFZVRA
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
87%
Stochastic
ODDS (%)
N/A
Bearish Trend 1 day ago
78%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
2%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
2%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
N/A
Bullish Trend 1 day ago
81%
Declines
ODDS (%)
N/A
Bearish Trend 11 days ago
77%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
83%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
ZVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VGIRX15.53N/A
N/A
Virtus Duff & Phelps Global Infras R6
FTIWX14.03N/A
N/A
Fidelity Advisor Asset Manager 20% I
EKJYX14.46N/A
N/A
Allspring Premier Large Co Gr Inst
MXXIX59.47N/A
N/A
Marsico Midcap Growth Focus Fund
SSCPX7.03N/A
N/A
Saratoga Small Capitalization I

FGHQF and

Correlation & Price change

A.I.dvisor tells us that FGHQF and ANL have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FGHQF and ANL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FGHQF
1D Price
Change %
FGHQF100%
N/A
ANL - FGHQF
25%
Poorly correlated
-0.72%
SKYE - FGHQF
15%
Poorly correlated
-2.99%
LEXX - FGHQF
9%
Poorly correlated
+0.67%
HMTXF - FGHQF
8%
Poorly correlated
+4.40%
ZVRA - FGHQF
4%
Poorly correlated
+0.09%
More

ZVRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZVRA has been loosely correlated with ATXS. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ZVRA jumps, then ATXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZVRA
1D Price
Change %
ZVRA100%
+3.98%
ATXS - ZVRA
40%
Loosely correlated
-1.48%
DNTH - ZVRA
37%
Loosely correlated
-2.28%
CRNX - ZVRA
37%
Loosely correlated
-1.05%
QURE - ZVRA
36%
Loosely correlated
+0.07%
ERAS - ZVRA
35%
Loosely correlated
-1.30%
More